Skip to content
  • Monday, 17 August 2026
  • 3:12 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
Neuroscience & Brain Research

Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies

Rifan Muazin Jul 17, 2026 0

New research conducted by neuroscientists at the Fralin Biomedical Research Institute at VTC has fundamentally questioned a decades-old paradigm regarding…

Read More
Neuroscience & Brain Research

Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies

Rifan Muazin Jul 2, 2026 0

New research emerging from the Fralin Biomedical Research Institute at VTC is fundamentally questioning the established framework used to study…

Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit IDPharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025Navigating the Diagnostic Labyrinth: Fragmentation Hinders Rare Disease Progress Despite Scientific LeapsArtificial Intelligence Systems Struggle with Cognitive Focus and Distraction Management in New Research Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ